Related Experiment Video
Updated: Aug 14, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and
R S Vasan1, M G Larson, E J Benjamin
1National Heart, Lung, and Blood Institute's Framingham Heart Study, Massachusetts 01702, USA.
Insights
Congestive heart failure (CHF) with normal left ventricular (LV) systolic function is common in the community, particularly in women. These patients face a fourfold increased mortality risk compared to those without CHF.
Area of Science:
- Cardiology
- Echocardiography
- Public Health
Background:
- Hospital studies indicate many congestive heart failure (CHF) patients have normal left ventricular (LV) systolic function.
- The community prevalence and prognosis of CHF with normal LV systolic function remain unclear.
Purpose of the Study:
- To determine the proportion of normal versus impaired LV systolic function in community-dwelling CHF patients.
- To compare long-term mortality between CHF patients with normal and impaired LV systolic function and matched controls.
Main Methods:
- A nested case-control study evaluated 73 Framingham Heart Study subjects with CHF and 146 matched controls.
- Impaired LV systolic function was defined as LV ejection fraction (LVEF) <0.50.
- Echocardiograms were analyzed, and mortality data were collected over a median follow-up of 6.2 years.
Main Results:
- 51% of CHF cases exhibited normal LVEF; 49% had reduced LVEF. Normal LVEF was more prevalent in women (65%), while reduced LVEF predominated in men (75%).
- CHF cases with normal LVEF had an 8.7% annual mortality vs. 3.0% for controls (aHR=4.06).
- CHF cases with reduced LVEF had an 18.9% annual mortality vs. 4.1% for controls (aHR=4.31).
Conclusions:
- Normal LV systolic function is frequent in community-based CHF and more common in women.
- While having lower mortality than reduced LVEF CHF, normal LVEF CHF patients face a fourfold increased mortality risk compared to non-CHF controls.
Objectives:
The purpose of this study was to assess the relative proportions of normal versus impaired left ventricular (LV) systolic function among persons with congestive heart failure (CHF) in the community and to compare their long-term mortality during follow-up.
Background:
Several hospital-based investigations have reported that a high proportion of subjects with CHF have normal LV systolic function. The prevalence and prognosis of CHF with normal LV systolic function in the community are not known.
Methods:
We evaluated the echocardiograms of 73 Framingham Heart Study subjects with CHF (33 women, 40 men, mean age 73 years) and 146 age- and gender-matched control subjects (nested case-control study). Impaired LV systolic function was defined as an LV ejection fraction (LVEF) <0.50.
Results:
Thirty-seven CHF cases (51%) had a normal LVEF; 36 (49%) had a reduced LVEF. Women predominated in the former group (65%), whereas men constituted 75% of the latter group. During a median follow-up of 6.2 years, CHF cases with normal LVEF experienced an annual mortality of 8.7% versus 3.0% for matched control subjects (adjusted hazards ratio = 4.06, 95% confidence interval 1.61 to 10.26). Congestive heart failure cases with reduced LVEF had an annual mortality of 18.9% versus 4.1% for matched control subjects (adjusted hazards ratio = 4.31, 95% confidence interval 1.98 to 9.36).
Conclusions:
Normal LV systolic function is often found in persons with CHF in the community and is more common in women than in men. Although CHF cases with normal LVEF have a lower mortality risk than cases with reduced LVEF, they have a fourfold mortality risk compared with control subjects who are free of CHF.
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation

